Using a new electronic tool to assess symptoms in head and neck cancer patients
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
['FUNDING_R01'] · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · NIH-10931436
This study is testing a new tool that helps doctors check in on head and neck cancer patients' symptoms in real-time, so they can provide better care and support, and it includes people from both rural and urban areas to make sure everyone can benefit.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10931436 on ClinicalTrials.gov |
What this research studies
This research focuses on implementing the NYU Electronic Patient Visit Assessment (ePVA) to improve symptom management for patients diagnosed with head and neck cancer. The ePVA is designed to capture patient-reported symptoms in real-time, allowing healthcare providers to intervene promptly and effectively. By integrating this tool with electronic health records, the research aims to enhance the detection of symptoms that often go unnoticed, ultimately improving patient quality of life and reducing the need for acute care. The study will involve both rural and urban populations to ensure diverse representation and access to this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with head and neck cancer who are undergoing treatment.
Not a fit: Patients with head and neck cancer who are not receiving treatment or those with advanced disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better symptom management and improved quality of life for head and neck cancer patients.
How similar studies have performed: Previous research has shown that patient-reported symptom monitoring can significantly improve cancer care outcomes, indicating a promising potential for this approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VAN CLEAVE, JANET H — UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
- Study coordinator: VAN CLEAVE, JANET H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center, Cancers, Comprehensive Cancer Center